Glucocorticoids (cortisol)

Cortisol is the principal glucocorticoid in humans and represents one of the most powerful endocrine signals linking the environment, stress, and internal homeostasis. Its function cannot be reduced to that of a simple “stress hormone”, but instead forms part of a regulatory system that coordinates energy availability, cardiovascular responses, immune tone, and tissue plasticity. Signal stability arises from the adrenal gland's ability to produce cortisol in a rhythmic and adaptive manner, while the final biological effect depends on how cortisol is transported in plasma, made available within tissues, and locally processed by enzymes that can amplify or suppress its action.

Glucocorticoid physiology is a paradigmatic example of the integration between organ endocrinology and molecular control. Adrenocortical biosynthesis requires a zonal enzymatic program that begins with cholesterol and proceeds through mitochondrial and endoplasmic reticulum steps finely regulated by adrenocorticotropic hormone (ACTH). Peripheral metabolism is not merely a disposal process, but a level of regulation that includes hepatic inactivation, conjugation, recirculation, and, above all, prereceptor control mediated by 11β-hydroxysteroid dehydrogenases. This page examines cortisol throughout its entire functional chain, from steroidogenesis to tissue-specific regulation of its action, including the genomic and non-genomic mechanisms of the glucocorticoid receptor.

The glucocorticoid system is designed to produce a signal that is both predictable and adaptive. Under basal conditions, cortisol secretion follows a circadian rhythm with a morning peak and nighttime nadir, upon which ultradian pulses are superimposed to modulate tissue exposure dynamically. This pattern synchronizes metabolism, blood pressure, alertness, and immune functions with the sleep-wake cycle. In parallel, the response to physical or psychological stress can rapidly remodel pulse amplitude and frequency, increasing cortisol availability when the body needs to sustain perfusion, blood glucose, and energy resources.

From an endocrinological perspective, glucocorticoid signaling cannot be equated with a single plasma concentration because the circulating hormone is largely protein-bound and because the final effect is determined by the amount of cortisol that reaches the receptor inside target cells. This step is governed by a combination of protein binding, permeation, and, above all, prereceptor control. Within tissues, cortisol can be regenerated from cortisone or inactivated before receptor binding, transforming the same circulating profile into different biological states in different anatomical sites. This principle explains why glucocorticoid physiology is highly compartmentalized and why some systemic conditions can modify tissue bioavailability without requiring primary adrenal dysfunction.

A further level of signal stabilization is provided by the filtering of active cortisol within mineralocorticoid-sensitive tissues. In the kidney, colon, and placenta, cortisol inactivation protects the mineralocorticoid receptor from inappropriate occupation, preserving the specificity of aldosterone signaling. In this way, a single steroid that is present at substantially higher concentrations than aldosterone remains compatible with the existence of two closely related receptors that perform different physiological functions.

Three principles explain why the cortisol signal is rhythmic in the bloodstream but selective within tissues:

• pulsatile adrenal output, regulated by the hypothalamic-pituitary-adrenal axis and adaptable to stress;
• plasma reservoir bound to corticosteroid-binding globulin (CBG) and albumin, with a small but biologically decisive free fraction;
• prereceptor control through 11β-hydroxysteroid dehydrogenases and cellular factors that modulate receptor access and responsiveness.

This conceptual architecture makes adrenocortical biosynthesis the natural starting point. The way in which the adrenal gland mobilizes cholesterol, organizes enzymatic steps, and responds to adrenocorticotropic hormone determines the quality and dynamics of the signal that will subsequently be transported, metabolized, and interpreted by tissues.

Cortisol synthesis occurs in the zona fasciculata of the adrenal cortex and requires an enzymatic program integrating the mitochondria and endoplasmic reticulum. The decisive step, in both quantitative and regulatory terms, is the access of cholesterol to the inner mitochondrial membrane, where the side-chain cleavage complex is located. Intracellular cholesterol transport is promoted by the steroidogenic acute regulatory protein (StAR), whose induction and activation represent a central component of the acute response to adrenocorticotropic hormone. In practice, the adrenal gland can rapidly increase steroid production not primarily by activating new enzymes, but by making the substrate available within the compartment in which steroidogenesis begins.

Once it reaches the mitochondrion, cholesterol is converted into pregnenolone by cytochrome P450 family 11 subfamily A member 1 (CYP11A1), also known as the cholesterol side-chain cleavage enzyme or P450scc. Pregnenolone then moves to the endoplasmic reticulum, where 3β-hydroxysteroid dehydrogenase enables the formation of progesterone and advances the sequence toward cortisol-producing precursors. In the human adrenocortical pathway, cytochrome P450 family 17 subfamily A member 1 (CYP17A1) plays an essential role in conferring the ability to produce cortisol-type glucocorticoids, distinguishing human physiology from that of species in which corticosterone is the principal glucocorticoid. The subsequent step, catalyzed by cytochrome P450 family 21 subfamily A member 2 (CYP21A2), leads to the formation of 11-deoxycortisol, which re-enters the mitochondrion for the final step.

The final phase is catalyzed by cytochrome P450 family 11 subfamily B member 1 (CYP11B1), also known as 11β-hydroxylase, which converts 11-deoxycortisol into cortisol. The zonal arrangement of enzymes is a structural principle: the zona fasciculata is organized to support continuous glucocorticoid production, whereas the zona glomerulosa prioritizes mineralocorticoid synthesis and the zona reticularis integrates the androgenic program. This compartmentalization is maintained by gradients of trophic signals and transcriptional networks that determine which enzymes are present, in what quantity, and with what capacity to respond to stimulation.

A crucial consideration is that steroidogenesis is an energy-intensive and redox-intensive process. Reactions catalyzed by cytochrome P450 enzymes require electron transfer and support systems that include nicotinamide adenine dinucleotide phosphate (NADPH) and specific reductase partners. Adrenocortical function is therefore sensitive to cellular metabolic status, cholesterol availability, and mitochondrial integrity. During prolonged stress, biosynthetic capacity increasingly depends on chronic regulation of enzyme expression and substrate availability, rather than solely on the acute response mediated by steroidogenic acute regulatory protein.

Adrenocortical biosynthesis should therefore be understood as a chain in which the physiological bottleneck is cholesterol mobilization, while the specificity of the final product is determined by zonal identity and the coordinated presence of cytochrome P450 enzymes and dehydrogenases. This provides the basis for understanding regulation by adrenocorticotropic hormone and the rhythms of secretion, which transform biosynthetic potential into a temporally organized endocrine signal.

The principal control of cortisol secretion is exerted by adrenocorticotropic hormone, released by the anterior pituitary gland in response to hypothalamic corticotropin-releasing hormone (CRH) and vasopressin. In adrenocortical cells, adrenocorticotropic hormone acts through the melanocortin 2 receptor (MC2R), which is coupled to G proteins and activates the cyclic adenosine monophosphate-protein kinase A pathway (cAMP-PKA). This signal rapidly increases cholesterol availability and the efficiency of the initial steps of steroidogenesis, increasing cortisol production within a short period. Under physiological conditions, this mechanism is responsible for both ultradian pulses and the system's ability to respond to acute stimuli.

In addition to acute control, adrenocorticotropic hormone exerts long-term trophic and transcriptional effects. Chronic stimulation promotes the expression of proteins involved in cholesterol uptake, the biogenesis of steroidogenic compartments, and the expression of key enzymes. This allows the adrenal gland to increase its production capacity when endocrine demand is sustained, but also explains why prolonged suppression of the axis reduces adrenocortical output and makes the system vulnerable to sudden stress. The distinction between acute and chronic regulation is therefore fundamental: the former modulates output from minute to minute, while the latter determines the overall endocrine capacity of the adrenal gland.

Rhythmic regulation is integrated with negative feedback exerted by glucocorticoids on the hypothalamus and pituitary gland. However, central perception of the signal is not identical to its peripheral action because it depends on local bioavailability and receptor sensitivity within neuroendocrine circuits. The same plasma cortisol level can therefore have different meanings according to protein binding, inflammatory status, and prereceptor modulation, while physiological fluctuations must be regarded as an integral part of function rather than as biological noise.

These concepts lead naturally to plasma transport. The protein-bound fraction, particularly the fraction bound to corticosteroid-binding globulin, is a structural component of signal stability and directly influences both the interpretation of biochemical values and the amount of cortisol available to tissues.

In plasma, cortisol is predominantly protein-bound, mainly to corticosteroid-binding globulin and, to a lesser extent, albumin. This binding creates a large circulating reservoir that stabilizes the signal and reduces fluctuations in the free fraction. The free fraction is quantitatively small but physiologically crucial because it can diffuse into interstitial compartments and interact with intracellular targets. Functionally, the system is designed to maintain continuity of availability while allowing rapid changes when production increases or when the affinity or quantity of binding proteins changes.

Corticosteroid-binding globulin is not merely a passive carrier. Under specific conditions, including inflammation and tissue stress, binding affinity can be modified by local phenomena involving changes in temperature, pH, and proteolytic processes. This introduces an important functional concept: plasma transport can help concentrate or release cortisol selectively at sites of inflammation, converting a systemic parameter into a more targeted local signal. This property helps explain why the relationship between total and free cortisol may change during critical illness and why measurement of total cortisol alone may be insufficient to describe actual biological exposure.

Changes in corticosteroid-binding globulin and albumin can modify total cortisol levels without producing a proportional change in the free fraction. This principle is fundamental when interpreting physiological and pathological changes, including conditions in which hepatic synthesis or consumption of transport proteins is altered. Protein-binding biology is therefore an integral component of glucocorticoid physiology and forms a natural bridge to the regulation of tissue access and prereceptor metabolism.

Once cortisol reaches the tissues, it must be made available near its receptor. This step depends on permeation, possible transporter-mediated efflux, and, above all, enzymatic cortisol-cortisone conversion, which amplifies or suppresses the signal before receptor binding.

Within tissues, cortisol is regulated by a system of interconversion with cortisone, mediated by 11β-hydroxysteroid dehydrogenases. This level of control is defined as prereceptor regulation because it modifies the hormone before it interacts with its receptor, determining how much active signal is actually available within the cell. 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1), expressed in the liver, adipose tissue, central nervous system, and other sites, tends in vivo to regenerate cortisol from cortisone, locally amplifying activation of the glucocorticoid receptor. Functionally, this allows a tissue to increase glucocorticoid action without requiring a parallel increase in adrenal secretion.

11β-hydroxysteroid dehydrogenase type 2 (11β-HSD2) performs the opposite function, rapidly inactivating cortisol to cortisone in tissues where mineralocorticoid specificity must be protected, particularly the kidney and colon, and critically within the placenta. Because the mineralocorticoid receptor binds cortisol with high affinity, inactivation is necessary to prevent cortisol from mimicking aldosterone. Mineralocorticoid action is therefore governed by aldosterone availability, while cortisol can continue to perform its glucocorticoid role without disrupting sodium-potassium homeostasis and blood pressure regulation.

Prereceptor control is also a mechanism for compartmentalizing the signal during stress and chronic disease. In some contexts, increased local regeneration of cortisol contributes to remodeling metabolism and inflammation within tissues, while inactivation may protect against excessive signaling. Consequently, circulating cortisol and the effective cortisol signal at receptor level may differ, with direct implications for the interpretation of biochemical parameters and for understanding systemic and regional effects.

This level of control is integrated with systemic clearance. The duration and intensity of the signal also depend on how cortisol is metabolized and removed, mainly by the liver and kidneys through reduction, oxidation, and conjugation processes.

Cortisol metabolism has two integrated functions. The first is signal termination, which reduces receptor exposure and allows the system to respond to rapid changes without accumulating excessive activity. The second is transformation into water-soluble metabolites that can be eliminated through processes including A-ring reduction, oxidation, and, above all, conjugation with glucuronide and sulfate. The liver is the principal site of metabolism, but the kidneys also contribute substantially to both transformation and metabolite excretion.

A central consideration is the interaction between metabolism and the free fraction. If clearance decreases, cortisol tends to increase, but the magnitude of the biological effect depends on changes in corticosteroid-binding globulin, the free fraction, and prereceptor control. During systemic illness, reduced metabolism and altered protein binding may coexist, making the relationship between total cortisol and biological signaling more complex. This explains why glucocorticoid physiology during critical illness cannot be interpreted simply as hyperproduction or hypoproduction, but rather as a remodeling of production, transport, and clearance.

Conjugation and elimination also interact with recirculation and with the heterogeneity of urinary steroid metabolite profiles, which reflect the integration of adrenal production and peripheral hepatic metabolism. This complexity is important because it demonstrates that cortisol is not an isolated signal, but a node connecting the adrenal glands, liver, and kidneys. This network becomes particularly relevant when interpreting biochemical measurements in the context of hepatic or renal dysfunction.

To understand the final biological effect, it is necessary to move from metabolic fate to mechanisms of action. Cortisol exerts most of its effects through the glucocorticoid receptor, a nuclear receptor capable of modulating transcriptional programs over response times ranging from minutes to hours, with profound systemic consequences.

Cortisol acts primarily through the glucocorticoid receptor (GR), encoded by NR3C1 and belonging to the nuclear receptor family. Under basal conditions, the glucocorticoid receptor is associated with chaperone and cofactor complexes that stabilize its conformation and regulate its cellular localization. Cortisol binding induces conformational changes that promote nuclear translocation and interaction with deoxyribonucleic acid and other regulatory proteins. This mechanism allows cortisol to convert an endocrine signal into coordinated control of gene expression.

Within the nucleus, the glucocorticoid receptor can bind to specific sequences known as glucocorticoid response elements (GREs), directly modulating transcription. The final effect depends on the recruitment of coregulators that alter chromatin accessibility, influence transcription initiation, and determine the intensity of the response. The same cortisol concentration can produce different responses in different tissues because the availability of coactivators and corepressors, epigenetic status, and interactions with other hormonal signals establish a tissue-specific context.

Genomic action explains the ability of glucocorticoids to regulate carbohydrate and lipid metabolism, protein turnover, cardiovascular function, and immune programs. In the liver, cortisol supports glucose production and energy availability during periods of increased demand, while in adipose tissue and muscle it coordinates substrate utilization and sensitivity to concurrent signals. In the immune system, genomic effects enable broad, multilevel modulation of inflammatory mediators, keeping the defensive response within limits compatible with tissue integrity.

An important aspect is the functional diversity of the glucocorticoid receptor. Isoforms and variants can alter sensitivity and the repertoire of regulated genes, contributing to interindividual differences and to glucocorticoid resistance or hypersensitivity in specific contexts. These regulatory layers make the glucocorticoid receptor more than a simple activation or inhibition switch. Instead, it acts as an integrator combining ligand intensity, transcriptional context, and protein interactions.

In addition to direct regulation through glucocorticoid response elements, the glucocorticoid receptor can modulate gene expression without directly binding to deoxyribonucleic acid, through interactions with pro-inflammatory transcription factors. This mechanism is essential for understanding the potent immunomodulatory activity of glucocorticoids and why their biological effects often arise from the integration of multiple pathways.

A fundamental component of glucocorticoid action is the modulation of inflammation through mechanisms that do not necessarily require direct binding of the glucocorticoid receptor to deoxyribonucleic acid. The glucocorticoid receptor can interfere with transcription factors such as nuclear factor kappa B (NF-κB) and activator protein 1 (AP-1), reducing the expression of pro-inflammatory genes while simultaneously inducing the production of anti-inflammatory mediators. This type of control is often described as transrepression and represents a key principle of glucocorticoid physiology: limiting the intensity and duration of the inflammatory response to prevent organ damage and excessive energy expenditure.

Integration with cellular pathways also includes modulation of kinases and secondary mediators involved in inflammatory signal transduction. Cortisol can reduce the availability of pro-inflammatory mediators, modulate tissue sensitivity to cytokines, and remodel endothelial responses, with effects on permeability, vascular tone, and cellular migration. Glucocorticoids therefore act as a physiological brake that does not suppress host defense completely, but prevents its excessive activation.

This capacity for integration also explains why glucocorticoid action is strongly context-dependent. During stress and infection, the body can increase cortisol output to support homeostasis while simultaneously preventing the inflammatory response from becoming self-destructive. However, when the same mechanism persists chronically or becomes excessive, the balance may shift toward unfavorable metabolic and immune effects. Glucocorticoid physiology therefore represents a continuous balance between adaptation and biological cost.

Alongside genomic mechanisms and indirect transcriptional interactions, rapid non-genomic actions also contribute to effects that develop over short periods. These pathways do not replace nuclear regulation, but expand the temporal repertoire of glucocorticoid signaling.

Cortisol can activate rapid non-genomic effects within minutes through mechanisms that include interactions with membrane structures, modulation of ion channels, and activation of cytoplasmic signaling pathways. In some cellular contexts, the glucocorticoid receptor can be associated with extranuclear compartments and modulate cascades such as mitogen-activated protein kinase (MAPK) or phosphoinositide 3-kinase (PI3K), rapidly influencing vascular tone, contractility, receptor trafficking, and responsiveness to catecholamines. This provides a basis for understanding why some glucocorticoid effects emerge before gene transcription can produce measurable changes in protein expression.

A further level of rapid action involves the mitochondria. Glucocorticoid signaling can influence mitochondrial function, reactive oxygen species production, and bioenergetic efficiency, thereby contributing to immediate metabolic adaptation. Functionally, cortisol therefore acts not only as a long-term programmer but also as an acute modulator of energy-response capacity.

Non-genomic actions have an integrative role: they increase the organism's flexibility in responding to stress and coordinate rapid systems, such as the cardiovascular and autonomic nervous systems, with the slower programs established through transcriptional regulation. The coexistence of genomic and non-genomic pathways allows glucocorticoid physiology to produce immediate responses while simultaneously consolidating prolonged adaptations.

This complexity leads to the final synthesis. Understanding cortisol requires the integration of rhythmic production, transport, prereceptor control, metabolism, and receptor responses, while also recognizing the interpretative limitations of biochemical parameters when they are considered outside their physiological and clinical context.

Cortisol physiology demonstrates that glucocorticoid signaling is the result of a complex chain: zonal biosynthesis regulated by adrenocorticotropic hormone, rhythmic release, binding to corticosteroid-binding globulin and albumin, availability of the free fraction, prereceptor cortisol-cortisone conversion, hepatic and renal metabolism, and, finally, genomic and non-genomic receptor integration. Each step can be remodeled by inflammatory status, hepatic and renal function, changes in transport proteins, and energy adaptations, producing biochemical profiles that do not always correspond to the same intensity of tissue signaling.

The predominance of protein-bound cortisol makes total cortisol values strongly dependent on transport proteins. In many contexts, the free fraction is the determinant most closely related to biological activity, but even free cortisol does not automatically describe receptor exposure in every tissue because prereceptor control can locally amplify or suppress the signal. This explains why endocrinological interpretation of cortisol must always consider the time of sampling, circadian rhythm, clinical context, and factors that alter corticosteroid-binding globulin and metabolism.

In conclusion, cortisol is an endocrine signal that combines stability and flexibility. Stability derives from adrenal biosynthetic capacity and the plasma reservoir, while flexibility arises from rhythmic regulation and prereceptor switching within tissues. Genomic action mediated by the glucocorticoid receptor explains systemic effects on metabolism and immunity, while non-genomic pathways complete the picture by providing rapid responses and integration with cardiovascular and autonomic signals. This perspective is essential for understanding both the physiology of stress and the conditions in which glucocorticoid signaling becomes maladaptive.